S&P 500 Futures
(0.08%) 5 331.25 points
Dow Jones Futures
(0.01%) 40 141 points
Nasdaq Futures
(0.11%) 18 657 points
Oil
(-0.29%) $79.83
Gas
(0.46%) $2.64
Gold
(1.28%) $2 448.40
Silver
(2.99%) $32.20
Platinum
(0.39%) $1 094.20
USD/EUR
(0.01%) $0.920
USD/NOK
(0.01%) $10.68
USD/GBP
(0.03%) $0.787
USD/RUB
(-0.33%) $90.67

Realtime updates for Organicell Regenerative [OCEL]

Exchange: OTC Sector: Healthcare Industry: Biotechnology
Last Updated4 Mar 2024 @ 15:14

-0.27% $ 2.74

Live Chart Being Loaded With Signals

Commentary (4 Mar 2024 @ 15:14):

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases...

Stats
Today's Volume 4 735.00
Average Volume 4 716.00
Market Cap 19.97M
EPS $-0.00114 ( 2023-07-30 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.567
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2023-06-29 Leider Harry L. Buy 500 000 Common Stock
2023-06-28 Leider Harry L. Buy 549 450 Common Stock
2023-12-19 Leider Harry L. Sell 5 248 Common Stock
2023-07-07 Skycrest Holdings, Llc Buy 320 710 Common Stock
2023-06-29 Skycrest Holdings, Llc Buy 200 000 Common Stock
INSIDER POWER
-78.51
Last 93 transactions
Buy: 116 969 610 | Sell: 385 387 546

Organicell Regenerative Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Organicell Regenerative Financials

Annual 2023
Revenue: $4.56M
Gross Profit: $4.05M (88.86 %)
EPS: $-0.990
FY 2023
Revenue: $4.56M
Gross Profit: $4.05M (88.86 %)
EPS: $-0.990
FY 2022
Revenue: $6.49M
Gross Profit: $5.74M (88.39 %)
EPS: $-1.570
FY 2021
Revenue: $5.60M
Gross Profit: $5.05M (90.21 %)
EPS: $-0.0100

Financial Reports:

No articles found.

Organicell Regenerative Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Organicell Regenerative

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19. The company also provides independent education, advertising, and marketing services to medical and other healthcare, anti-aging, and regenerative service providers. It has a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection; and an agreement with Oklahoma State University to evaluate Zofin for the treatment of respiratory diseases caused by virus infections of pandemic potential. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators